As monotherapies, ceralasertib and RT enhanced the tumour quadrupling time in both NT (16 days; 22 days, respectively) and PTEN-depleted (2 days; 5 days, respectively) CDX models in comparison to vehicle-treated mice. Here, PTEN is linked to neoplasm.